MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
AxoGen DPO Ratio 2011-2026 | AXGN
Annual DPO Ratio AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.4 | 79.6 | 102 | 91.2 | 83.7 | 109 | 174 | 128 | 127 | 249 | 157 | 123 | - | - | 238 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 249 | 34.4 | 130 |
Quarterly DPO Ratio AxoGen
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 48.7 | - | 115 | 102 | 121 | - | 73.6 | 74.8 | 122 | - | 167 | 178 | 157 | - | 119 | 133 | 130 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.96 | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 178 | 7.96 | 111 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
52.3 | $ 3.89 | 6.06 % | $ 160 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
EDAP TMS S.A.
EDAP
|
116 | $ 4.17 | 0.6 % | $ 156 M |  France |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 7.27 | -3.32 % | $ 1.09 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.21 | -0.68 % | $ 1.34 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.71 | -0.56 % | $ 415 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.51 | -2.3 % | $ 65.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 12.41 | -3.2 % | $ 351 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | 0.16 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 72.24 | 0.53 % | $ 3.94 B |  Britain |
 |
Delcath Systems
DCTH
|
56 | $ 11.56 | 0.7 % | $ 414 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
76.3 | $ 11.72 | 0.6 % | $ 464 M |  Curacao |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.83 | -0.82 % | $ 34.7 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 26.97 | -0.33 % | $ 228 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.18 | 0.36 % | $ 885 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
112 | $ 6.98 | 1.82 % | $ 211 M | Canada |
 |
Insulet Corporation
PODD
|
22.5 | $ 152.77 | -0.9 % | $ 10.7 B | USA |
 |
Globus Medical
GMED
|
33.1 | $ 79.44 | 2.08 % | $ 10.7 B | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.37 | 0.4 % | $ 6.57 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.37 | -1.05 % | $ 1.13 B | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 283.81 | -0.57 % | $ 108 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 44.68 | 0.95 % | $ 1.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 87.68 | -0.48 % | $ 3.05 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 78.93 | -1.26 % | $ 46.2 B | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 66.89 | -1.33 % | $ 2.27 B | USA |